2013 Deep Research Report on China Human Use Rabies Vaccine Industry

Publisher Name :
Date: 20-Jan-2013
No. of pages: 123

2013 Deep Research Report on China Human Use Rabie Vaccine Industry was professional and depth research report on China Human Use Rabie Vaccine industry. This report has firstly introduced Human Use Rabie Vaccine definition classification industry chain etc related information. Then introduced Human Use Rabie Vaccine manufacturing technology and product specifications, And then summary statistics China major Human Use Rabie Vaccine manufacturers Human Use Rabie Vaccine (Hamster Kidney Cell) Human Use Rabie Vaccine (Vero) Human Use Rabie Vaccine (Chicken Embryo Cell) 2010-2016 Human Use Rabie Vaccine capacity production supply demand shortage and Human Use Rabie Vaccine selling price cost gross margin and production value, and also introduced China 16 manufacturers company basic information, 2010-2016 Human Use Rabie Vaccine capacity production price cost gross margin production value China market share etc details information. In the end, this report introduced 4 Million Boxes/year Human Use Rabie Vaccine project feasibility analysis and investment return analysis. Also give related research conclusions and development trend analysis of China Human Use Rabie Vaccine industry. In a word, it was a depth research report on China Human Use Rabie Vaccine industry. And thanks to the support and assistance from Human Use Rabie Vaccine industry chain related experts and enterprises during Research Team survey and interviews.

2013 Deep Research Report on China Human Use Rabies Vaccine Industry

Table of Contents

Chapter One Human Use Rabie Vaccine (Hamster Kidney Cell) Industry Overview    1
1.1 Human Use Rabie Vaccine (Hamster Kidney Cell) Definition    1
1.2 Human Use Rabie Vaccine (Hamster Kidney Cell) Product Specification    2
1.3 Human Use Rabie Vaccine (Hamster Kidney Cell) Price Analysis    3
1.4 Human Use Rabie Vaccine (Hamster Kidney Cell) Manufacturing Process    4
1.5 Human Use Rabie Vaccine (Hamster Kidney Cell) Cost Structure    5
1.6 Human Use Rabie Vaccine (Hamster Kidney Cell) Industry Overview    6

Chapter Two Human Use Rabie Vaccine (Vero Cell) Industry Overview    7
2.1 Human Use Rabie Vaccine (Vero Cell) Definition    7
2.2 Human Use Rabie Vaccine (Vero Cell) Product Specification    7
2.3 Human Use Rabie Vaccine (Vero Cell) Price Analysis    9
2.4 Human Use Rabie Vaccine (Vero Cell) Manufacturing Process    10
2.5 Human Use Rabie Vaccine (Vero Cell) Cost Structure    11
2.6 Human Use Rabie Vaccine (Vero Cell) Industry Overview    12

Chapter Three Human Use Rabie Vaccine (Chicken Embryo Cell) Industry Overview    13
3.1 Human Use Rabie Vaccine (Chicken Embryo Cell) Definition    13
3.2 Human Use Rabie Vaccine (Chicken Embryo Cell) Product Specification    13
3.3 Human Use Rabie Vaccine (Chicken Embryo Cell) Price Analysis    17
3.4 Human Use Rabie Vaccine (Chicken Embryo Cell) Manufacturing Process    18
3.5 Human Use Rabie Vaccine (Chicken Embryo Cell) Cost Structure    18
3.6 Human Use Rabie Vaccine (Chicken Embryo Cell) Industry Overview    19

Chapter Four Human Use Rabie Vaccine Industry Chain Analysis    20
4.1 Raw Materials Market Analysis    20
4.2 Prophylactic Immunization Demand Analysis    21
4.3 Raw Materials-Human Use Rabie Vaccine -Vaccinated People Industry Chain Analysis    23

Chapter Five Human Use Rabie Vaccine Production Supply Sales Demand Market Status and Forecast    25
5.1 China Human Use Rabie Vaccine Capacity Production Overview    25
5.2 China Regional Human Use Rabie Vaccine Production and Market Share    34
5.3 China Human Use Rabie Vaccine Sales and Market Share    36
5.4 China Key Manufacturers Human Use Rabie Vaccine Capacity Utilization Rate    39
5.5 China Human Use Rabie Vaccine (BHK Vero Cell Chicken Embryo Cell) Capacity Production and Market Share    40
5.6 Human Use Rabie Vaccine Demand Overview    42
5.7 Human Use Rabie Vaccine Supply Demand Shortage    43
5.8 Human Use Rabie Vaccine Cost Price Production Value Gross Margin    44
5.9 Human Use Rabie Vaccine Import Export Consumption    46

Chapter Six Human Use Rabie Vaccine Key Manufacturer Analysis    46
6.1 Yatai Group    46
6.2 Dalian Hissen    51
6.3 Langzhou Institute of Biological Products    55
6.4 Henan Puxin Biological Engineering (2011 Sold To Yatai Group)    58
6.5 Forwell Boipharm (2010 Stop)    62
6.6 Chengda Boitechnology    66
6.7 Liaoning Yisheng    72
6.8 Promise Biological    75
6.9 BCHT Pharm (Jilin Maifeng)    78
6.10 Changchun Changsheng    82
6.11 Zhejiang Vacinbio-pharmaceutical    86
6.12 Wuhan Institute of Biological Products (2011 Stop)    91
6.13 Jiangsu Yansheng Biological (2010 Stop)    94
6.14 Dalian Jingang Andi Biological (2009 Stop)    96
6.15 Sanofipasteur    97
6.16 Chiron Behring    102
6.17 Other Manufacturers    108

Chapter Seven Human Use Rabie Vaccine New Project Investment Feasibility Analysis    109
7.1 Human Use Rabie Vaccine Project SWOT Analysis    109
7.2 4 Million Box/Year Human Use Rabie Vaccine New Project Investment Feasibility Analysis    110

Chapter Eight Human Use Rabie Vaccine Industry Research Conclusions    111

List Of Tables and Figures

Figure Human Use Rabie Vaccine (Hamster Kidney Cell) Product Picture    1
Table Human Use Rabie Vaccine (Hamster Kidney Cell) Product Specifications List    2
Table 2010-2016 China Human Use Rabie Vaccine (Hamster Kidney Cell) Price (RMB/Box) (Generally: 1 Box=5Dose*1.0ml/dose) List    3
Figure Human Use Rabie Vaccine (Hamster Kidney Cell) Manufacturing Process Flow    4
Table Human Use Rabie Vaccine (Hamster Kidney Cell) Product Line Equipments List    5
Table 2010-2016 China Human Use Rabie Vaccine (Hamster Kidney Cell) Price Cost Gross (RMB/Box) Gross Margin List    5
Table 2012 China Human Use Rabie Vaccine (Hamster Kidney Cell) Cost Structure (RMB/Box)    6
Figure Human Use Rabie Vaccine (Vero Cell) Product Picture    7
Table Human Use Rabie Vaccine (Vero Cell) Product Specifications List    7
Table 2010-2016 China Human Use Rabie Vaccine (Vero Cell)Price (RMB/Box) (Generally: 1 Box=5Dose*1.0ml/dose) List    9
Figure Human Use Rabie Vaccine (Vero Cell) Manufacturing Process Flow    10
Table Human Use Rabie Vaccine (Vero Cell) Product Line Equipments List    11
Table 2010-2016 China Human Use Rabie Vaccine (Vero Cell) Price Cost Gross (RMB/Box) Gross Margin List    11
Table 2012 China Human Use Rabie Vaccine (Vero Cell) Cost Structure (RMB/Box)    11
Figure Human Use Rabie Vaccine (Chicken Embryo Cell) Product Picture    13
Table Human Use Rabie Vaccine (Chicken Embryo Cell) Product Specifications List    13
Table 2010-2016 China Human Use Rabie Vaccine (Chicken Embryo Cell) Price (RMB/Box) (Generally: 1 Box=5Dose*1.0ml/dose) List    17
Figure Human Use Rabie Vaccine (Chicken Embryo Cell) Manufacturing Process Flow    18
Table 2010-2016 China Human Use Rabie Vaccine (Chicken Embryo Cell) Price Cost Gross (RMB/Box) Gross Margin List    18
Table 2012 China Human Use Rabie Vaccine (Chicken Embryo Cell) Cost Structure (RMB/Box)    19
Table 2010-2016 China Human Use Rabie Vaccine 199 Culture Medium Price (RMB/bottle) List    20
Table 2010-2016 China Human Serum Albumin Price (RMB/g) List    20
Table 2010-2016 China Bovine Serum Albumin Price (RMB/Bottle) List    21
Table 2010-2016 China Embryonated Egg Price (RMB/Piece) List    21
Table 2007-2013 China Rabies Patients Number of Deaths (People) List    21
Table 2010-2016 China Human Use Rabie Vaccine Demand (10K Box) List    22
Figure 2010-2016 China Human Use Rabie Vaccine Demand (10K Box) and Growth Rate    22
Figure Raw Materials-Human Use Rabie Vaccine - Vaccinated People Industry Chain Structure    23
Table Raw Materials-Human Use Rabie Vaccine - Vaccinated People Shipment and Supply Relationshio List    24
Table 2010-2016 China Key Manufacturers Human Use Rabie Vaccine Capacity and Toal Capacity (10K Box) List    25
Table 2010-2016 China Key Manufacturers Human Use Rabie Vaccine Capacity Market Share List    25
Table 2010-2016 China Key Manufacturers Human Use Rabie Vaccine Production and Total Production (10K Box) List    26
Table 2010-2016 China Key Manufacturers Human Use Rabie Vaccine Production Market Share List    27
Figure 2010-2016 China Human Use Rabie Vaccine Capacity Production (10K Box) and Growth Rate    28
Table 2010-2016 China Human Use Rabie Vaccine Capacity Utilization Rate List    28
Table 2010-2016 China Key Manufacturers Human Use Rabie Vaccine (Hamster Kidney Cell) Capacity and Toal Capacity (10K Box) List    29
Table 2010-2016 China Key Manufacturers Human Use Rabie Vaccine (Hamster Kidney Cell) Capacity Market Share List    29
Table 2010-2016 China Key Manufacturers Human Use Rabie Vaccine (Hamster Kidney Cell) Production and Total Production (10K Box) List    29
Table 2010-2016 China Key Manufacturers Human Use Rabie Vaccine (Hamster Kidney Cell) Production Market Share List    30
Figure 2010-2016 China Human Use Rabie Vaccine (Hamster Kidney Cell) Capacity Production (10K Box) and Growth Rate    30
Table 2010-2016 China Human Use Rabie Vaccine (Hamster Kidney Cell) Capacity Utilization Rate List    31
Table 2010-2016 China Key Manufacturers Human Use Rabie Vaccine (Vero Cell) Capacity and Toal Capacity (10K Box) List    31
Table 2010-2016 China Key Manufacturers Human Use Rabie Vaccine (Vero Cell) Capacity Market Share List    31
Table 2010-2016 China Key Manufacturers Human Use Rabie Vaccine (Vero Cell) Production and Total Production (10K Box) List    32
Table 2010-2016 China Key Manufacturers Human Use Rabie Vaccine (Vero Cell) Production Market Share List    32
Figure 2010-2016 China Human Use Rabie Vaccine (Vero Cell) Capacity Production (10K Box) and Growth Rate    33
Table 2010-2016 China Human Use Rabie Vaccine (Vero Cell) Capacity Utilization Rate List    34
Table 2010-2016 Liaoning Guangzhou Jilin Zhejiang etc Regions Human Use Rabie Vaccine +Human Use Rabie Vaccine Capacity (10K Box) List    34
Table 2010-2016 Liaoning Guangzhou Jilin Zhejiang etc Regions Human Use Rabie Vaccine Capacity Market Share List    35
Table 2010-2016 Liaoning Guangzhou Jilin Zhejiang etc Regions Human Use Rabie Vaccine Production (10K Box) List    35
Table 2010-2016 Liaoning Guangzhou Jilin Zhejiang etc Regions Human Use Rabie Vaccine Production Market Share List    35
Table 2010-2016 China Human Use Rabie Vaccine Sales (10K Box) List    36
Table 2010-2016 China Human Use Rabie Vaccine Sales (10K Box) and Market Share List    36
Table 2010-2016 China Human Use Rabie Vaccine (Hamster Kidney Cell) Sales (10K Box) List    37
Table 2010-2016 China Human Use Rabie Vaccine (Hamster Kidney Cell) Sales (10K Box) and Market Share List    37
Table 2010-2016 China Human Use Rabie Vaccine (Vero Cell) Sales (10K Box) List    38
Table 2010-2016 China Human Use Rabie Vaccine (Vero Cell) Sales (10K Box) and Market Share List    38
Table 2010-2016 China Human Use Rabie Vaccine (Chicken Embryo Cell) Sales (10K Box) List    38
Table 2010-2016 China Human Use Rabie Vaccine (Chicken Embryo Cell) Sales (10K Box) and Market Share List    39
Table 2010-2016 China Key Manufacturers Human Use Rabie Vaccine Capacity Utilization Rate List    39
Table 2010-2016 China Key Manufacturers Human Use Rabie Vaccine (Hamster Kidney Cell) Capacity Utilization Rate List    40
Table 2010-2016 China Key Manufacturers Human Use Rabie Vaccine (Vero Cell) Capacity Utilization Rate List    40
Table 2010-2016 China Human Use Rabie Vaccine (BHK Vero Cell Chicken Embryo Cell) Capacity    40
Table 2010-2016 China Human Use Rabie Vaccine (BHK Vero Cell Chicken Embryo Cell) Capacity Market Share List    41
Table 2010-2016 China Human Use Rabie Vaccine (BHK Vero Cell Chicken Embryo Cell) Production    41
Table 2010-2016 China Human Use Rabie Vaccine (BHK Vero Cell Chicken Embryo Cell) Production Market Share List    41
Table 2010-2016 China Human Use Rabie Vaccine (BHK Vero Cell Chicken Embryo Cell) Sales    42
Table 2010-2016 China Human Use Rabie Vaccine (BHK Vero Cell Chicken Embryo Cell) Sales Market Share List    42
Table 2010-2016 China Human Use Rabie Vaccine Demand (10K Box) List    43
Table 2010-2016 China Human Use Rabie Vaccine Supply Demand Shortage (10K Box) List    43
Table 2010-2016 China Human Use Rabie Vaccine Production (10K Box) Price Cost Gross (RMB/Box) Production Value (10K RMB) Gross Margin List    44
Table 2010-2016 China Human Use Rabie Vaccine (Hamster Kidney Cell) Production (10K Box) Price Cost Gross (RMB/Box) Production Value (10K RMB) Gross Margin List    44
Table 2010-2016 China Human Use Rabie Vaccine (Vero Cell) Production (10K Box) Price Cost Gross (RMB/Box) Production Value (10K RMB) Gross Margin List    45
Table 2010-2016 China Human Use Rabie Vaccine (Chicken Embryo Cell) Production (10K Box) Price Cost Gross (RMB/Box) Production Value (10K RMB) Gross Margin List    45
Table 2010-2016 China Human Use Rabie Vaccine Import Export Consumption (10K Box) List    46
Table Yatai Group Company Information Table (Product Application Market Position Capacity Expansion Plan Contact Information etc 12 Items)    46
Figure Yatai Group Human Use Rabie Vaccine (Hamster Kidney Cell)Production Picture    49
Table Yatai Group Human Use Rabie Vaccine (Hamster Kidney Cell)Product Specifications List    49
Table 2010-2016 Yatai Group Human Use Rabie Vaccine (Hamster Kidney Cell)Capacity Production (10K Box) Price Cost Gross (RMB/Box) Production Value (10K RMB) Gross Margin List    50
Figure 2010-2016 Yatai Group Human Use Rabie Vaccine (Hamster Kidney Cell) Capacity Production (10K Box) and Growth Rate    50
Table Dalian Hissen Company Information Table (Product Application Market Position Capacity Expansion Plan Contact Information etc 12 Items)    51
Figure Dalian Hissen Human Use Rabie Vaccine (Hamster Kidney Cell)Production Picture    52
Table Dalian Hissen Human Use Rabie Vaccine (Hamster Kidney Cell)Product Specifications List    52
Table 2010-2016 Dalian Hissen Human Use Rabie Vaccine (Hamster Kidney Cell)Capacity Production (10K Box) Price Cost Gross (RMB/Box) Production Value (10K RMB) Gross Margin List    54
Figure 2010-2016 Dalian Hissen Human Use Rabie Vaccine (Hamster Kidney Cell) Capacity Production (10K Box) and Growth Rate    54
Table Langzhou Institute of Biological Products  Company Information Table (Product Application Market Position Capacity Expansion Plan Contact Information etc 12 Items)    55
Figure Langzhou Institute of Biological Products Human Use Rabie Vaccine (Hamster Kidney Cell)Production Picture    57
Table Langzhou Institute of Biological Products Human Use Rabie Vaccine (Hamster Kidney Cell)Product Specifications List    57
Table 2010-2016 Langzhou Institute of Biological Products Human Use Rabie Vaccine (Hamster Kidney Cell)Capacity Production (10K Box) Price Cost Gross (RMB/Box) Production Value (10K RMB) Gross Margin List    57
Figure 2010-2016 Langzhou Institute of Biological Products Human Use Rabie Vaccine (Hamster Kidney Cell) Capacity Production (10K Box) and Growth Rate    58
Table Henan Puxin Biological Engineering Company Information Table (Product Application Market Position Capacity Expansion Plan Contact Information etc 12 Items)    59
Figure Henan Puxin Biological Engineering Human Use Rabie Vaccine (Hamster Kidney Cell)Production Picture    60
Table Henan Puxin Biological Engineering Human Use Rabie Vaccine (Hamster Kidney Cell)Product Specifications List    60
Table 2010-2016 Henan Puxin Biological Engineering Human Use Rabie Vaccine (Hamster Kidney Cell)Capacity Production (10K Box) Price Cost Gross (RMB/Box) Production Value (10K RMB) Gross Margin List    61
Figure 2010-2016 Henan Puxin Biological Engineering Human Use Rabie Vaccine (Hamster Kidney Cell) Capacity Production (10K Box) and Growth Rate    62
Table Forwell Boipharm  Company Information Table (Product Application Market Position Capacity Expansion Plan Contact Information etc 12 Items)    62
Figure Forwell Boipharm Human Use Rabie Vaccine (Hamster Kidney Cell)Production Picture    64
Table Forwell Boipharm Human Use Rabie Vaccine (Hamster Kidney Cell)Product Specifications List    64
Table Chengda Boitechnology Company Information Table (Product Application Market Position Capacity Expansion Plan Contact Information etc 12 Items)    66
Figure Chengda Boitechnology Human Use Rabie Vaccine (Vero Cell) Production Picture    68
Table Chengda Boitechnology Human Use Rabie Vaccine (Vero Cell) Product Specifications List    68
Table 2010-2016 Chengda Boitechnology Human Use Rabie Vaccine (Vero Cell) Capacity  Production (万人份)、价格、成本、利润(元/人份)产值(万元)利润率一览表    71
Figure 2010-2016 Chengda Boitechnology Human Use Rabie Vaccine (Vero Cell) Capacity Production (10K Box) and Growth Rate    71
Table Liaoning Yisheng Company Information Table (Product Application Market Position Capacity Expansion Plan Contact Information etc 12 Items)    72
Figure Liaoning Yisheng Freeze-dried Human Use Rabie Vaccine (Vero Cell) Production Picture    73
Table Liaoning Yisheng Human Use Rabie Vaccine (Vero Cell) Product Specifications List    73
Table 2010-2016 Liaoning Yisheng Human Use Rabie Vaccine (Vero Cell) Capacity Production (10K Box) Price Cost Gross (RMB/Box) Production Value (10K RMB) Gross Margin List    74
Figure 2010-2016 Liaoning Yisheng Human Use Rabie Vaccine (Vero Cell) Capacity Production (10K Box) and Growth Rate    74
Table Promise Biological Company Information Table (Product Application Market Position Capacity Expansion Plan Contact Information etc 12 Items)    75
Figure Promise Biological Freeze-dried Human Use Rabie Vaccine (Vero Cell) Production Picture    76
Table Promise Biological Human Use Rabie Vaccine (Vero Cell) Product Specifications List    76
Table 2010-2016 Promise Biological Human Use Rabie Vaccine (Vero Cell) Capacity Production (10K Box) Price Cost Gross (RMB/Box) Production Value (10K RMB) Gross Margin List    77
Figure 2010-2016 Promise Biological Human Use Rabie Vaccine (Vero Cell) Capacity Production (10K Box) and Growth Rate    78
Table BCHT Pharm Company Information Table (Product Application Market Position Capacity Expansion Plan Contact Information etc 12 Items)    78
Figure BCHT Pharm Human Use Rabie Vaccine (Vero Cell) Production Picture    80
Table BCHT Pharm Human Use Rabie Vaccine (Vero Cell) Product Specifications List    80
Table 2010-2016 BCHT Pharm Human Use Rabie Vaccine (Vero Cell) Capacity Production (10K Box) Price Cost Gross (RMB/Box) Production Value (10K RMB) Gross Margin List    81
Figure 2010-2016 BCHT Pharm Human Use Rabie Vaccine (Vero Cell) Capacity Production (10K Box) and Growth Rate    82
Table Changchun Changsheng  Company Information Table (Product Application Market Position Capacity Expansion Plan Contact Information etc 12 Items)    82
Figure Changchun Changsheng Human Use Rabie Vaccine (Vero Cell) Production Picture    84
Table Changchun Changsheng  Human Use Rabie Vaccine (Vero Cell) Product Specifications List    84
Table 2010-2016 Changchun Changsheng Human Use Rabie Vaccine (Vero Cell) Capacity Production (10K Box) Price Cost Gross (RMB/Box) Production Value (10K RMB) Gross Margin List    85
Figure 2010-2016 Changchun Changsheng Human Use Rabie Vaccine (Vero Cell) Capacity Production (10K Box) and Growth Rate    86
Table Zhejiang Vacinbio-pharmaceutical Company Information Table (Product Application Market Position Capacity Expansion Plan Contact Information etc 12 Items)    86
Figure Zhejiang Vacinbio-pharmaceutical Freeze-dried Human Use Rabie Vaccine (Vero Cell) Production Picture    88
Table Zhejiang Vacinbio-pharmaceutical Human Use Rabie Vaccine (Vero Cell) Product Specifications List    88
Table 2010-2016 Zhejiang Vacinbio-pharmaceutical Human Use Rabie Vaccine (Vero Cell) Capacity Production (10K Box) Price Cost Gross (RMB/Box) Production Value (10K RMB) Gross Margin List    90
Figure 2010-2016 Zhejiang Vacinbio-pharmaceutical Human Use Rabie Vaccine (Vero Cell) Capacity Production (10K Box) and Growth Rate    90
Table Wuhan Institute of Biological Products Company Information Table (Product Application Market Position Capacity Expansion Plan Contact Information etc 12 Items)    91
Figure Wuhan Institute of Biological Products Freeze-dried Human Use Rabie Vaccine (Vero Cell) Production Picture    92
Table Wuhan Institute of Biological Products Human Use Rabie Vaccine (Vero Cell) Product Specifications List    92
Table 2010-2016 Wuhan Institute of Biological Products Human Use Rabie Vaccine (Vero Cell) Capacity Production (10K Box) Price Cost Gross (RMB/Box) Production Value (10K RMB) Gross Margin List    93
Figure 2010-2016 Wuhan Institute of Biological Products Human Use Rabie Vaccine (Vero Cell) Capacity Production (10K Box) and Growth Rate    94
Table Jiangsu Yansheng Biological Company Information Table (Product Application Market Position Capacity Expansion Plan Contact Information etc 12 Items)    95
Table Dalian Jingang Andi Biological Company Information Table (Product Application Market Position Capacity Expansion Plan Contact Information etc 12 Items)    96
Table Sanofipasteur Company Information Table (Product Application Market Position Capacity Expansion Plan Contact Information etc 12 Items)    97
Figure Sanofipasteur Human Use Rabie Vaccine (Vero Cell) Production Picture    99
Table Sanofipasteur Human Use Rabie Vaccine (Vero Cell) Product Specifications List    99
Table 2010-2016 Sanofipasteur Human Use Rabie Vaccine (Vero Cell) Capacity Production (10K Box) Price Cost Gross (RMB/Box) Production Value (10K RMB) Gross Margin List    101
Figure 2010-2016 Sanofipasteur Human Use Rabie Vaccine (Vero Cell) Capacity Production (10K Box) and Growth Rate    101
Table Chiron Behring Company Information Table (Product Application Market Position Capacity Expansion Plan Contact Information etc 12 Items)    102
Figure Chiron Behring Human Use Rabie Vaccine (Chicken Embryo Cell) Production Picture    104
Table Chiron Behring Human Use Rabie Vaccine (Chicken Embryo Cell) Product Specifications List    105
Table 2010-2016 Chiron Behring Human Use Rabie Vaccine (Chicken Embryo Cell) Capacity Production (10K Box) Price Cost Gross (RMB/Box) Production Value (10K RMB) Gross Margin List    107
Figure 2010-2016 Chiron Behring Human Use Rabie Vaccine (Chicken Embryo Cell) Capacity Production (10K Box) and Growth Rate    108
Table 2013 China Human Use Rabie Vaccine New Project SWOT Analysis List    109
Table 4 Million Box/Year Freeze-dried Human Use Rabie Vaccine (Vero Cell) New Project Investment Return Rate and Feasibility Analysis    110

  • Global Stem Cell Therapy Industry Witnesses Steady Growth
    Stem cell research which is one of the most contemporary areas of biology has developed rapidly in the last couple of years. Increased funding in stem cell research by both government and private organizations is one of the main drivers in the stem cell therapy industry. Stem cells are used in various medical therapies such [...]
  • Global Lubricant Market Driven by Increased Demand in Automotive Industry
    With growth in the automobile industry, the demand for lubricants has also increased. The robust growth in manufacturing with increase in industrial production, particularly in countries such as China and India are also fueling the demand for lubricants. In 2013, the global market for lubricants had reached a value of 123.64 billion USD. By 2020, [...]
  • Global Cybersecurity Market Driven by Increase in Cyber Attacks
    In recent years, the global market for cybersecurity has grown steadily, with the rapid adoption of cloud-based services. As more and more corporate and government organizations are realizing the importance of protecting data and intellectual property, the market for cybersecurity is going to expand. In 2014, the global market for cybersecurity was valued at 95.60 [...]
  • Global Epilepsy Drug Market Continues to Grow Steadily
    The global epilepsy drug market has grown steadily in recent years with increased sales of anti-epileptic drugs which are targeted at reducing seizures. Epilepsy is a condition which affects the brain and is characterized with repeated seizures in the patient. Treatment for epilepsy usually involves the use of medicines known as anti-epileptic drugs which prevents [...]
  • Global Meat and Poultry Product Market to Witness Steady Growth
    As global demand for meat and poultry products continues to rise, the market for meat and poultry is also expected to grow steadily. The market for meat and poultry products is driven by rise in disposable income, growing awareness among consumers about the importance of adding protein to their diet, and change in eating habits. [...]
  • Graft-Versus-Host Disease (GVHD) Treatment Market worth $407 million by 2018
  • The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …

  • Poland Pharmaceutical Industry Growing at 8.3% CAGR to 2020
  • Factors such as the growing elderly population, increasing availability of affordable medicines, and transparent regulatory guidelines will provide the necessary impetus for the growth of the Polish pharmaceutical market, but a decrease in mark-up prices and the country’s stringent drug …

  • Asia-Pacific, Led by China, Drive the Global Methanol Industry
  • China is driving the global methanol industry, with tremendous demand from both its energy and petrochemicals sectors. It accounts for 87.9% of Asia-Pacific’s (APAC) methanol capacity, and 51.9% of the global methanol capacity. Despite a large planned capacity increase in …

  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • Opportunity Analyzer: Celiac Disease – Opportunity Analysis and Forecast to 2018
    Published: 19-Nov-2014        Price: US $7995 Onwards        Pages: 166
    There are no pharmacological treatments that are indicated for celiac disease and the current standard of care treatment involves a gluten free diet (GFD). Steroids and immunosuppressants are used to reduce symptoms in severe cases, targeting approximately 5% of the celiac disease patient population and there are no preventative medications. The anticipated launch of Alba/Teva’s larazotide acetate in 2018 in the US and 2019 in 5EU, followed by the launch of Alvine/AbbVie’s latiglutenase in 2......
  • Influenza Vaccines Market & Forecast – Worldwide Analysis
    Published: 14-Nov-2014        Price: US $1490 Onwards        Pages: 179
    The Influenza vaccines market represent an attractive market characterize by sturdy growth prospects. Increasing awareness, growing vaccination coverage in the emerging countries, rising government support for immunization against Seasonal Influenza and increased focus on the production of treatments for vulnerable populations by introducing new vaccines and vaccines with a better route of administration are the main drivers to galvanized Influenza vaccines market. Seasonal Influenza vaccines......
  • General Anxiety Disorder – Pipeline Review, H2 2014
    Published: 14-Nov-2014        Price: US $2000 Onwards        Pages: 40
    Global Markets Direct's, ‘General Anxiety Disorder Pipeline Review, H2 2014', provides an overview of the General Anxiety Disorder's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for General Anxiety Disorder, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases......
  • Acquired (Autoimmune) Hemolytic Anemia – Pipeline Review, H2 2014
    Published: 14-Nov-2014        Price: US $2000 Onwards        Pages: 55
    Global Markets Direct's, ‘Acquired (Autoimmune) Hemolytic Anemia - Pipeline Review, H2 2014', provides an overview of the Acquired (Autoimmune) Hemolytic Anemia's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Acquired (Autoimmune) Hemolytic Anemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest u......
  • EpiCast Report: Celiac Disease – Epidemiology Forecast to 2023
    Published: 10-Nov-2014        Price: US $3995 Onwards        Pages: 45
    Celiac disease is an autoimmune disease that occurs in individuals who consume gluten-containing foods but are intolerant to gluten, a protein found in many grains, such as wheat, rye, and barley. In celiac disease, the body’s immune system attacks and destroys the villi of the small intestine and thus interferes with nutrient absorption. Celiac disease can be difficult to diagnose because the symptoms vary between individuals and are non-specific, such as abdominal bloating and pain, diarrhea......
  • Russia: Antibiotics – Market Report. Analysis and Forecast to 2020
    Published: 10-Nov-2014        Price: US $1900 Onwards        
    "Report will be delivered within 3-4 working days" The report provides an in-depth analysis of the Russian Market of Antibiotics. It presents the latest data of the market size and volume, domestic production, exports and imports, price dynamics and turnover in the industry. The report shows the sales data, allowing you to identify the key drivers and restraints. You can find here a strategic analysis of key factors influencing the market. Forecasts illustrate how the market will be transform......
  • Russia: Vaccines For Human Medicine – Market Report. Analysis and Forecast to 2020
    Published: 10-Nov-2014        Price: US $1900 Onwards        
    "Report will be delivered within 3-4 working days" The report provides an in-depth analysis of the Russian Market of Vaccines For Human Medicine. It presents the latest data of the market size and volume, domestic production, exports and imports, price dynamics and turnover in the industry. The report shows the sales data, allowing you to identify the key drivers and restraints. You can find here a strategic analysis of key factors influencing the market. Forecasts illustrate how the market w......
  • EU: Antibiotics – Market Report. Analysis and Forecast to 2020
    Published: 10-Nov-2014        Price: US $1900 Onwards        
    "Report will be delivered within 3-4 working days" The report provides an in-depth analysis of the EU Market of Antibiotics. It presents the latest data of the market size and volume, domestic production, exports and imports, price dynamics and turnover in the industry. The report shows the sales data, allowing you to identify the key drivers and restraints. You can find here a strategic analysis of key factors influencing the market. Forecasts illustrate how the market will be transformed i......
  • EU: Vaccines For Human Medicine – Market Report. Analysis and Forecast to 2020
    Published: 10-Nov-2014        Price: US $1900 Onwards        
    "Report will be delivered within 3-4 working days" The report provides an in-depth analysis of the EU Market of Vaccines For Human Medicine. It presents the latest data of the market size and volume, domestic production, exports and imports, price dynamics and turnover in the industry. The report shows the sales data, allowing you to identify the key drivers and restraints. You can find here a strategic analysis of key factors influencing the market. Forecasts illustrate how the market will ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs